http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8ee6e6132e44817bfbbb7509fee2032
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Paridaens |
| name | Robert Paridaens |
| given-name | Robert |
| organization-name | Multidisciplinary Breast Center and Gynecological Oncology, Leuvens Kanker Instituut, Leuven, Belgium Fertility and Cancer Unit, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium i Department of Internal Medicine, University Hospital Leuven, Belgium. 1Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.; 4Department of Medical Oncology, University Hospitals Leuven, Leuven, Belgium. 1Laboratory for Experimental Oncology, Department of General Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium; Department of Medical Oncology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Belgium e Department of Internal Medicine, University Hospital Leuven, Leuven, Belgium From the European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation; Harvard Medical School, Boston, MA; Breast Center, Kantonsspital, St Gallen; International Breast Cancer Study Group, Swiss Group for Clinical Cancer Research, Bern; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Danish Breast Cancer Cooperative Group,... Department of Medical Oncology, University Hospitals Leuven, Leuven, Belgium James P. Morden, Lucy Kilburn, Claire Snowdon, and Judith M. Bliss, The Institute of Cancer Research; Hanna Nicholas, Cancer Research UK; R. Charles Coombes, Imperial College London, London; Gianfilippo Bertelli, Singleton Hospital, Swansea; Robert Coleman, Weston Park Hospital, Sheffield; Lesley Fallowfield, University of Sussex, Brighton; David Dodwell, St James Hospital, Leeds, United Kingdom; Isabel Alvarez, Hospital Donostia, GEICAM Spanish Breast Cancer Group, San Sebastian, Spain; Alan S. Coates,... Multidisciplinary Breast Centre; Department of Medical Oncology, UZ-Katholieke Universiteit Leuven, Leuven, Belgium Leuven Cancer Institute, University Hospital Gasthuisberg, Leuven, Belgium 1Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium and2 From the Institut Jules Bordet; European Organization for Research and Treatment of Cancer, Brussels; Hasselt University, Diepenbeek; International Drug Development Institute, Louvain-la-Neuve; University Hospital Gasthuisberg, Leuven, Belgium; Indiana University-Purdue University, Indianapolis, IN; Astra-zeneca, Macclesfield; Nottingham City Hospital, Nottingham, United Kingdom; Medizinische Hochschule, Hannover, Germany; University of Alberta, Edmonton, Alberta, Canada; Breast Cancer Research Institute... Judith M. Bliss, Lucy S. Kilburn, and James Morden, The Institute of Cancer Research, Sutton; Robert E. Coleman, Weston Park Hospital, Sheffield; Justine Reise and R. Charles Coombes, Imperial College London, London, United Kingdom; John F. Forbes, University of Newcastle, Newcastle Mater Hospital, Newcastle, New South Wales, Australia; Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia; Stephen E. Jones, US Oncology Research, Houston,... From the Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Harvard School of Public Health; Frontier Science and Technology Research Foundation, Boston, MA; IBCSG Coordinating Center and Inselspital; Swiss Group for Clinical Cancer Research, Bern; Senology Center of Eastern Switzerland, Kantonsspital, St Gallen; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;... From the Departments of Pathology, Obstetrics and Gynecology, Surgery-Senology, and General Medical Oncology and Multidisciplinary Breast Centre, University Hospital Gasthuisberg, and Departments of Human Genetics and Electrical Engineering, Katholieke Universiteit Leuven; and Department of Molecular and Developmental Genetics, Flanders Institute for Biotechnology, Leuven, Belgium From the Medical Oncology Unit, Oncologisch Centrum Sint-Augustinus, Wilrijk, Belgium; Philippine General Hospital, Manilla, Philippines; Jehangi Hospital, Pune, India; Kidwa Memorial Institute of Oncology, Bangalore, India; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India; University Hospital Gasthuisberg, Leuven, Belgium; US Oncology, Dallas, TX; Es Salud, Lima, Peru; Pfizer Oncology, New York, NY Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm From the Multidisciplinary Breast Centre and Departments of General Medical Oncology, Pathology, Gynecology, and Radiotherapy, University Hospitals Leuven; Department of Electrical Engineering, Katholieke Universiteit Leuven, Leuven, Belgium; Comprehensive Cancer Centre South, Eindhoven Cancer Registry, Eindhoven, the Netherlands; and Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway. Department of Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium From the Dana-Farber Cancer Institute, Boston, MA; Oncology Center AZ St Augustinus, Antwerp; UZ Gasthuisberg, Leuven; and Institut Jules Bordet, Brussels, Belgium; Cancer Hospital, Chinese Academy of Medical Sciences; Chinese People's Liberation Army General Hospital; and The Hospital Affiliated Academy of Military Medical Science, Beijing, China; Cancer Institute of New Jersey, New Brunswick, NJ; Deenanath Mangeshkar Hospital, Pune; and Tata Memorial Hospital, Mumbai, India; Dartmouth-Hitchcock Medical... From the International Breast Cancer Study Group (IBCSG); IBCSG Coordinating Center, Bern; Swiss Group for Clinical Cancer Research (SAKK), Senology Center of Eastern Switzerland, Kantonsspital, St Gallen; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; University of Sydney, Sydney; Australian New Zealand Breast Cancer Trials Group, University of Newcastle, Newcastle Mater Hospital, Newcastle, New South Wales; Box Hill and Maroondah Hospitals, Melbourne, Australia; IBCSG Statistical... From the Katholieke Universiteit Leuven; Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven; Virga Jesse Hospital, Hasselt, Belgium; Auckland Breast Cancer Registry, Greenlane Clinical Centre; Regional Cancer Centre, Auckland City Hospital, Auckland, New Zealand; Ullevål University; and Norwegian Radium Hospital, Oslo, Norway. Multidisciplinary Breast Center, Department of Gynecological Oncology, and ESAT-SCD, Universitaire Ziekenhuizen Gasthuisberg, Katholieke Universiteit, Leuven, Belgium From the Departments of Urology, Radiotherapy and Oncology, University Hospitals Katholieke Universiteit Leuven, Leuven; Departments of Urology, St.-Jozef Kliniek, Izegem and Oostende; Algemeen Ziekenhuis St.-Erasmus, Antwerpen; St.-Maartensziekenhuis, Kortrijk, Belgium From the Hasselt University, Diepenbeek; International Drug Development Institute, Louvain-la-Neuve; University Hospital Gasthuisberg, Leuven; Institut Jules Bordet; and European Organization for Research and Treatment of Cancer, Brussels, Belgium; Indiana University-Purdue University, Indianapolis, IN; Astra Zeneca, Macclesfield; and Nottingham City Hospital, United Kingdom; Medizinische Hochschule, Hannover, Germany; University of Alberta, Edmonton, Canada; Breast Cancer Research Institute–La Prandie,... From the Vall d′Hebron University Hospital, Barcelona, Spain; Weill Cornell Medical College, New York, NY; Baylor-Charles A. Sammons Cancer Center; Texas Oncology PA; US Oncology, Dallas; US Oncology, Houston, TX; Eisai Medical Research, Woodcliff Lake, NJ; Comprehensive Cancer Centers of Nevada, Henderson, NV; Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds; Eisai, London, United Kingdom; Centre de Lutte Contre le Cancer René Gauducheau, Nantes; Institut Claudius Régaud,... Department of General Medical Oncology and Laboratory for Experimental Oncology University Hospitals Leuven Leuven Cancer Institute KU Leuven Leuven Belgium From the Departments of Obstetrics and Gynecology, Radiology, Rheumatology, Electrical Engineering, Orthopedic Surgery, Medical Oncology, and the Multidisciplinary Breast Center, Leuven Kanker Instituut, Katholieke Universiteit Leuven, University Hospitals KU, Leuven, Belgium |
Incoming Links
Total number of triples: 135.